5 Reasons AGP Limited Could Be Your Next Big Pharma Pick
As Pakistan's pharmaceutical sector evolves rapidly post-deregulation, AGP Limited (AGP) stands out as one of the most attractive investment opportunities. With a strong product mix,...
Pharma Stock Valuations Are at a Discount, Is Now the Time to Buy?
Pakistan’s pharmaceutical sector has quietly morphed into a compelling value play. Despite major regulatory relief, margin expansion, and earnings growth, valuations across the board remain...
Can Pakistan’s local drugmakers outperform multinationals?
Pakistan’s pharmaceutical sector has entered a phase of structural transformation, and one question stands out: Can local drug manufacturers truly outperform multinational companies (MNCs)? Based...
Pharma sector earnings rise, valuations fall: is it a buying opportunity?
The pharmaceutical sector in Pakistan delivered a strong performance in 1QCY25, with listed companies showing robust profitability driven by favorable macro and regulatory developments. Using...
Why AGP Is the Smart Pharma Pick in 2025?
Pakistan's pharmaceutical sector continues to present a compelling investment case, supported by strong earnings growth, favorable regulatory developments, and improving macroeconomic conditions. In light of...
AGP EPS Forecast
According to our database, the following research houses have published their AGP EPS Forecast
AGP Target Prices 2025
According to our database, AGP has an average analyst price target for Dec 2025 of Rs. 225 based on estimates of 5 different analysts. This...